LRRC8A Mediates Ischemic Neuronal Injury by Potentiating NMDA Receptor Activity and Activating Mitochondrial Apoptotic Pathway
Cell Biology International · 2026
DOI: 10.1002/cbin.70118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology International, 2026. Verfasst von Chengli Qian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Apoptosis, Receptors, N-Methyl-D-Aspartate, Neurons, Mitochondria. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hubei Provincial Natural Science Foundation, Medical Sci-Tech Innovation Platform of Zhongnan Hospital, Wuhan University.
Abstract (Originalsprache)
Brain ischemia induces neuronal apoptosis, a key event in stroke pathology, but the underlying mechanisms remain incompletely understood. This study investigates the role of the volume‐regulated anion channel subunit leucine‐rich repeat‐containing protein 8 A (LRRC8A) in ischemia‐induced neuronal damage. In a rat model of middle cerebral artery occlusion (MCAO) and in cultured neurons under oxygen‐glucose deprivation (OGD), ischemia/hypoxia rapidly upregulated LRRC8A expression in apoptotic neurons. Knockdown of lrrc8a via small interfering RNA (siRNA) attenuated brain infarction, improved neurological deficits, and reduced neuronal apoptosis. Mechanistically, lrrc8a knockdown suppressed the activation of the mitochondrial Bax/Bcl‐2/Caspase‐9/Caspase‐3 apoptotic pathway. Furthermore, lrrc8a knockdown reversed OGD‐induced hyperactivation of NMDA receptors (NMDARs) and weakened the enhanced interaction between LRRC8A and the obligatory NMDAR subunit GluN1, which was predicted by structural modeling. These findings reveal that cerebral ischemia upregulates neuronal LRRC8A, which may promote NMDAR hyperactivity via interaction with GluN1, thereby triggering mitochondrial apoptosis. LRRC8A represents a potential therapeutic target for mitigating neuronal apoptosis in ischemic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
- Hubei Polytechnic Institute, School of Medical Science, Xiaogan, Hubei, China.
- Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
- Department of Neurology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
- Wuhan Institute for Neuroscience and Neuroengineering, South-Central University for Nationalities, Wuhan, Hubei, China.
- College of Life Sciences, South-Central University for Nationalities, Wuhan, Hubei, China.
Förderung
- National Natural Science Foundation of China
- Hubei Provincial Natural Science Foundation
- Medical Sci-Tech Innovation Platform of Zhongnan Hospital, Wuhan University
- Science and Technology Innovation Cultivation Fund of Zhongnan Hospital, Wuhan University
Zitieren
APA
Qian, C., Huang, L., Chen, Y., Lv, J., Wang, Z., Dai, J., & Luo, Y. (2026). LRRC8A Mediates Ischemic Neuronal Injury by Potentiating NMDA Receptor Activity and Activating Mitochondrial Apoptotic Pathway. Cell Biology International. https://doi.org/10.1002/cbin.70118
Vancouver
Qian C, Huang L, Chen Y, Lv J, Wang Z, Dai J, et al. LRRC8A Mediates Ischemic Neuronal Injury by Potentiating NMDA Receptor Activity and Activating Mitochondrial Apoptotic Pathway. Cell Biology International. 2026. doi:10.1002/cbin.70118
BibTeX
@article{Qian2026,
author = {Qian, Chengli and Huang, Linshu and Chen, Ying and Lv, Jianghao and Wang, Zhuo and Dai, Jiapei and Luo, Yi},
title = {LRRC8A Mediates Ischemic Neuronal Injury by Potentiating NMDA Receptor Activity and Activating Mitochondrial Apoptotic Pathway},
journal = {Cell Biology International},
year = {2026},
doi = {10.1002/cbin.70118}
}
EUVIMED